FIELD: medicine, pharmaceutical industry. SUBSTANCE: invention relates to medicinal forms containing recombinant interferon and used for prophylaxis and treatment of viral diseases. An antiviral agent comprises recombinant alpha-, beta- or gamma-interferon, immunomodulating agent, antibacterial agent and/or anti- inflammatory preparation, stabilizing agent and pharmaceutically acceptable special additions. The agent is made as a liquid or soft, or solid medicinal form. EFFECT: expanded assortment of antiviral medicinal agents. 19 cl, 9 tbl
Title | Year | Author | Number |
---|---|---|---|
CURATIVE AGENT | 2000 |
|
RU2187332C1 |
CONDOM LUBRICANT | 2000 |
|
RU2187329C1 |
ANTIVIRAL, ANTIBACTERIAL AND ANTICANDIDOSIS AGENT | 2000 |
|
RU2187328C1 |
ANTIVIRUS MEANS IN LIPOSOME FORM | 2000 |
|
RU2176518C1 |
RECOMBINANT INTERFERON-BASE ANTIVIRAL AGENT AS OINTMENT, SUPPOSITORY, CREAM, LINIMENT | 1999 |
|
RU2150291C1 |
MEDICINAL PREPARATION | 2000 |
|
RU2187331C1 |
MEDICINAL PREPARATION FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS DISEASES | 2001 |
|
RU2185840C1 |
INTRANASAL AGENT | 2002 |
|
RU2220739C1 |
DRUG HERPFERON-2 POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANALGESIC ACTION FOR LOCAL AND EXTERNAL APPLICATION | 2012 |
|
RU2488405C1 |
ANTIVIRAL MEDICATION - NASAL DROPS | 2010 |
|
RU2437676C1 |
Authors
Dates
2002-08-20—Published
2000-12-18—Filed